Stereoselective synthesis of beta-nucleosides

A technology of nucleoside compounds and compounds, applied in drug combination, organic chemistry, antineoplastic drugs, etc.

Active Publication Date: 2013-05-08
PHARMAESSENTIA CORP
View PDF9 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, none of these research and development results are satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stereoselective synthesis of beta-nucleosides
  • Stereoselective synthesis of beta-nucleosides
  • Stereoselective synthesis of beta-nucleosides

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0044] The present invention relates to an efficient method for the stereoselective synthesis of 2'-deoxynucleosides, more specifically gemcitabine, and novel intermediates produced in this method.

[0045] Conventional chemical transformations can be used to practice the invention. Those skilled in the art can determine the appropriate chemicals, solvents, protecting groups and reaction conditions for this transformation. Relevant information is described, for example, in R. Larock, Comprehensive Organic Transformations, VCH Publishers (1989); T.W. Greene and P.G.M. Wuts, Protective Groups in Organic Synthesis, 3rd edition, John Wiley and Sons (1999); L. Fieser and M. . Fieser, Fieser and Fieser's Reagents for Organic Synthesis, John Wiley and Sons (1994); with L. Paquette ed. Encyclopedia of Reagents for Organic Synthesis, John Wiley and Sons (1995) and other editions of these. Embodiments of the methods of the invention are described herein for purposes of illustration.

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A method of stereoselectively synthesizing a [beta]-nucleoside, e.g., 2'-deoxy-2,2'-difluorocytidine, is described. The method includes reacting a tetrahydrofuran compound of the following formula, wherein R1, R2, R3, R4 and L are defined as in the specification, with a nucleobase derivative in the presence of an oxidizing agent.

Description

technical field [0001] The present invention relates to the synthesis technique of β-nucleoside. Background technique [0002] 2'-Deoxynucleosides and their analogs are important therapeutic agents. For example, gemcitabine, ie, 2'-deoxy-2,2'-difluorocytidine, can be used to treat viral infections and cancer. See, eg, US Patent Nos. 4,526,988 and 4,808,614 applications. [0003] Typically, each 2'-deoxynucleoside has more than one chiral center, and multiple stereoisomers can be formed. Not all stereoisomers are therapeutically active. Several stereoselective synthetic routes to 2-deoxy-β-nucleosides have been developed. But none of these research and development results are satisfactory. [0004] Therefore, there is a need to develop a more efficient route for the stereoselective synthesis of 2'-deoxynucleosides. Contents of the invention [0005] One aspect of the present invention relates to a method for synthesizing a β-nucleoside compound of formula (I): [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07H19/12C07H19/06
CPCC07H15/18C07H19/06A61P35/00
Inventor 简崇训简斌书黄正谷
Owner PHARMAESSENTIA CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap